Successful treatment of psoriatic arthritis with rituximab

Annals of the Rheumatic Diseases

Volumn 67, Issue 11, 2008, Pages 1647-1648

  Cohen, Jean David ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB;

ADULT; CASE REPORT; DIGESTIVE INTOLERANCE; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; ENDOCARDITIS; ERYTHROCYTE SEDIMENTATION RATE; GASTROINTESTINAL DISEASE; HAND RADIOGRAPHY; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SEPTICEMIA; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; FOLLOW-UP STUDIES; HAND JOINTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 54349109184     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.085290     Document Type: Letter

References (8)

1. Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006;54:2793-806.
2. Narat S, Gandla J, Hoffbrand AV, Hughes RG, Mehta AB. Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica 2005;90:1273-4.
3. Vigna-Perez M, Hernandez-Castro B, Paredes-Saharopulos O, Portales-Perez D, Baranda L, Abud-Mendoza C, et al. Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther 2006;8:R83.
4. Levine TD. Rituximab in the treatment of dermatomyositis: an open-label pilot study. Arthritis Rheum 2005;52:601-7.
5. Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, et al. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. Arthritis Rheum 2005;52:2740-50.
6. Singh F, Weinberg JM. Partial remission of psoriasis following therapy for non-Hodgkin lymphoma. Cutis 2005;76:186-8.
7. Taylor WJ, Gladman DD, Helliwell PS, Marchesoni A, Mease P, Mielants H, et al. Classification criteria for psoriatic arthritis: results from the CASPAR study group. Arthritis Rheum 2006;54:2665- 73.
8. Cañete JD, Santiago B, Sanmarti R, Palacin A, Gil B, Graell E, et al. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann Rheum Dis 2007;66:720-6.